Therapyx

About:

TherapyX is a privately held development-stage biotechnology company.

Website: http://therapyxinc.com/

Top Investors: National Institute of Allergy and Infectious Diseases

Description:

TherapyX is a privately held development-stage biotechnology company committed to innovating their industry and changing the future of pharmaceuticals by engaging in the discovery and development of microparticulate immune therapeutics to treat infectious disease, immune-mediated inflammatory disorders and cancer.

Total Funding Amount:

$2.8M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Buffalo, New York, United States

Founded Date:

Contact Email:

dauci(AT)therapyxinc.com

Founders:

Nejat K. Egilmez

Number of Employees:

11-50

Last Funding Date:

2020-08-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai